EQUITY Equity (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the six months ended June 30, 2026: | | | | | | | | | | | | | | | | | | | Cash Flow Hedge | | Cumulative Foreign Currency Translation Adjustments | | Total | | (in thousands) | | Balance at December 31, 2025 | $ | 3,872 | | | $ | (118,744) | | | $ | (114,872) | | Other comprehensive income (loss) before reclassifications | 1,097 | | | (23,050) | | | (21,953) | | | Amount reclassified from AOCI | (5,241) | | | — | | | (5,241) | | | Net other comprehensive loss | (4,144) | | | (23,050) | | | (27,194) | | | Balance at June 30, 2026 | $ | (272) | | | $ | (141,794) | | | $ | (142,066) | |
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net income (loss) per common share because such securities are anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | Restricted stock and deferred stock—unvested | 696,934 | | | 1,188,300 | | | 3,171,415 | | | 1,188,300 | | | | | | | | | | | Conversion shares related to the convertible senior notes | 11,944,810 | | | 14,946,450 | | | 21,170,304 | | | 14,946,450 | | | Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding | 12,641,744 | | | 16,134,750 | | | 24,341,719 | | | 16,134,750 | |
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | | | Weighted average common shares—basic | 232,838,912 | | | 231,845,412 | | | 232,621,161 | | | 231,534,852 | | | Effect of dilutive securities: | | | | | | | | | Stock options and restricted stock | 1,971,925 | | | 2,572,016 | | | — | | | 2,930,952 | | | Convertible senior notes | 9,225,494 | | | — | | | — | | | 192,804 | | | Weighted average common shares—diluted | 244,036,331 | | | 234,417,428 | | | 232,621,161 | | | 234,658,608 | |
|